IBDEI33V ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49601,1,3,0)
 ;;=3^Chr Resp Failure
 ;;^UTILITY(U,$J,358.3,49601,1,4,0)
 ;;=4^J96.10
 ;;^UTILITY(U,$J,358.3,49601,2)
 ;;=^5008350
 ;;^UTILITY(U,$J,358.3,49602,0)
 ;;=J96.01^^191^2474^11
 ;;^UTILITY(U,$J,358.3,49602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49602,1,3,0)
 ;;=3^Acute Resp Failure w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,49602,1,4,0)
 ;;=4^J96.01
 ;;^UTILITY(U,$J,358.3,49602,2)
 ;;=^5008348
 ;;^UTILITY(U,$J,358.3,49603,0)
 ;;=J96.02^^191^2474^10
 ;;^UTILITY(U,$J,358.3,49603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49603,1,3,0)
 ;;=3^Acute Resp Failure w/ Hypercap
 ;;^UTILITY(U,$J,358.3,49603,1,4,0)
 ;;=4^J96.02
 ;;^UTILITY(U,$J,358.3,49603,2)
 ;;=^5008349
 ;;^UTILITY(U,$J,358.3,49604,0)
 ;;=J96.21^^191^2474^2
 ;;^UTILITY(U,$J,358.3,49604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49604,1,3,0)
 ;;=3^Ac/Chr Resp Failure w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,49604,1,4,0)
 ;;=4^J96.21
 ;;^UTILITY(U,$J,358.3,49604,2)
 ;;=^5008354
 ;;^UTILITY(U,$J,358.3,49605,0)
 ;;=J96.22^^191^2474^1
 ;;^UTILITY(U,$J,358.3,49605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49605,1,3,0)
 ;;=3^Ac/Chr Resp Failure w/ Hypercapnia
 ;;^UTILITY(U,$J,358.3,49605,1,4,0)
 ;;=4^J96.22
 ;;^UTILITY(U,$J,358.3,49605,2)
 ;;=^5008355
 ;;^UTILITY(U,$J,358.3,49606,0)
 ;;=J96.11^^191^2474^35
 ;;^UTILITY(U,$J,358.3,49606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49606,1,3,0)
 ;;=3^Chr Resp Failure w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,49606,1,4,0)
 ;;=4^J96.11
 ;;^UTILITY(U,$J,358.3,49606,2)
 ;;=^5008351
 ;;^UTILITY(U,$J,358.3,49607,0)
 ;;=J96.12^^191^2474^34
 ;;^UTILITY(U,$J,358.3,49607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49607,1,3,0)
 ;;=3^Chr Resp Failure w/ Hypercap
 ;;^UTILITY(U,$J,358.3,49607,1,4,0)
 ;;=4^J96.12
 ;;^UTILITY(U,$J,358.3,49607,2)
 ;;=^5008352
 ;;^UTILITY(U,$J,358.3,49608,0)
 ;;=J96.91^^191^2474^51
 ;;^UTILITY(U,$J,358.3,49608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49608,1,3,0)
 ;;=3^Respiratory Failure,Unspec w/ Hypoxia
 ;;^UTILITY(U,$J,358.3,49608,1,4,0)
 ;;=4^J96.91
 ;;^UTILITY(U,$J,358.3,49608,2)
 ;;=^5008357
 ;;^UTILITY(U,$J,358.3,49609,0)
 ;;=J96.92^^191^2474^50
 ;;^UTILITY(U,$J,358.3,49609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49609,1,3,0)
 ;;=3^Respiratory Failure,Unspec w/ Hypercapnia
 ;;^UTILITY(U,$J,358.3,49609,1,4,0)
 ;;=4^J96.92
 ;;^UTILITY(U,$J,358.3,49609,2)
 ;;=^5008358
 ;;^UTILITY(U,$J,358.3,49610,0)
 ;;=J44.0^^191^2474^30
 ;;^UTILITY(U,$J,358.3,49610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49610,1,3,0)
 ;;=3^COPD w/ Acute Lower Resp Infection
 ;;^UTILITY(U,$J,358.3,49610,1,4,0)
 ;;=4^J44.0
 ;;^UTILITY(U,$J,358.3,49610,2)
 ;;=^5008239
 ;;^UTILITY(U,$J,358.3,49611,0)
 ;;=J44.1^^191^2474^29
 ;;^UTILITY(U,$J,358.3,49611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49611,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,49611,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,49611,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,49612,0)
 ;;=J45.20^^191^2474^18
 ;;^UTILITY(U,$J,358.3,49612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49612,1,3,0)
 ;;=3^Asthma,Mild Intermittent,Uncomplicated
 ;;^UTILITY(U,$J,358.3,49612,1,4,0)
 ;;=4^J45.20
 ;;^UTILITY(U,$J,358.3,49612,2)
 ;;=^5008242
 ;;^UTILITY(U,$J,358.3,49613,0)
 ;;=J45.21^^191^2474^16
 ;;^UTILITY(U,$J,358.3,49613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49613,1,3,0)
 ;;=3^Asthma,Mild Intermittent w/ Acute Exacerbation
